GTJA: Continuous iteration of anti-tumor therapies, domestic new drugs welcome breakthroughs.

GTJA focuses on products with significant differentiation advantages and leading companies in innovative segments.

Zhitong FinanceMar 16 21:18 ET

Calculating The Intrinsic Value Of Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SZSE:300255)

Simply Wall StMar 3 23:06 ET

Hebei Changshan Biochemical Pharmaceutical (300255.SZ): The innovative drug Aibenna peptide developed is currently in the professional review stage.

On February 14, Gelonghui reported that Hebei Changshan Biochemical Pharmaceutical (300255.SZ) stated on the investor interaction platform that the innovative drug Aibennate is currently in the professional review stage. The new drug approval involves many issues, and the company has been actively promoting the aforementioned work to strive for the early approval of Aibennate, providing more treatment options for patients.

Gelonghui FinanceFeb 14 02:41 ET

Changshan Biochemical Pharmaceutical Enrolls First Patient in Drug Trial

MT NewswiresFeb 13 21:51 ET

Hebei Changshan Biochemical Pharmaceutical (300255.SZ): The first subject in the phase I clinical trial of CSCJC3456 has been enrolled.

Hebei Changshan Biochemical Pharmaceutical (300255.SZ) announced that the company has entered into an agreement with its wholly-owned subsidiary Changshan Kaijie Health Biological Pharmaceutical Research and Development (Hebei...)

Zhitong FinanceFeb 13 02:58 ET

Hebei Changshan Biochemical Pharmaceutical (SZSE:300255) Shareholder Returns Have Been Stellar, Earning 240% in 5 Years

Simply Wall StFeb 10 22:56 ET